HomeIGMS • NASDAQ
add
IGM Biosciences Inc
Previous close
$6.20
Day range
$1.87 - $2.19
Year range
$1.87 - $22.50
Market cap
124.28M USD
Avg Volume
225.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 516.00K | 1.38% |
Operating expense | 18.76M | 50.00% |
Net income | -61.43M | 0.90% |
Net profit margin | -11.91K | 2.25% |
Earnings per share | -1.01 | 2.88% |
EBITDA | -62.08M | 3.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 218.79M | -43.46% |
Total assets | 304.51M | -35.81% |
Total liabilities | 225.56M | 2.30% |
Total equity | 78.95M | — |
Shares outstanding | 59.46M | — |
Price to book | 4.66 | — |
Return on assets | -50.22% | — |
Return on capital | -112.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -61.43M | 0.90% |
Cash from operations | -38.38M | 4.33% |
Cash from investing | 12.99M | -33.57% |
Cash from financing | 1.20M | -97.31% |
Net change in cash | -24.20M | -200.54% |
Free cash flow | -18.68M | 32.72% |
About
Founded
1993
Website
Employees
198
